Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Self‐Assembling Peptide‐Adjuvant Conjugate (SaPAC) Platform for Precision Cancer Immunotherapy. Local targets link to admitted publications; unresolved targets remain external evidence.
Peptide‐Based Vaccine for Cancer Therapies
10.3389/fimmu.2023.1210044 · 2023 · External reference
Therapeutic Peptides: Historical Perspectives, Current Development Trends, and Future Directions
10.1016/j.bmc.2017.06.052 · 2018 · External reference
Personalized Neoantigen Vaccination with Synthetic Long Peptides: Recent Advances and Future Perspectives
10.7150/thno.38742 · 2020 · External reference
Peptide‐Based Nanomaterials: Self‐Assembly, Properties and Applications
10.1016/j.bioactmat.2021.09.029 · 2022 · External reference
Therapeutic Peptides: Chemical Strategies Fortify Peptides for Enhanced Disease Treatment Efficacy
10.1007/s00726-025-03454-5 · 2025 · External reference
Once‐Weekly Semaglutide in Adults with Overweight or Obesity
10.1056/nejmoa2032183 · 2021 · External reference
The Future of Personalized Cancer Vaccines
10.1158/2159-8290.cd-25-0300 · 2025 · External reference
10.1038/s41587‐026‐03018‐2
10.1038/s41587‐026‐03018‐2 · External reference
Personalized Neoantigen Vaccine NEO‐PV‐01 with Chemotherapy and Anti‐PD‐1 as First‐Line Treatment for Non‐Squamous Non‐Small Cell Lung Cancer
10.1016/j.ccell.2022.08.003 · 2022 · External reference
A Multi‐Adjuvant Personal Neoantigen Vaccine Generates Potent Immunity in Melanoma
10.1016/j.cell.2025.06.019 · 2025 · External reference
Neoantigen Vaccine Generates Intratumoral T Cell Responses in Phase Ib Glioblastoma Trial
10.1038/s41586-018-0792-9 · 2019 · External reference
A Phase Ib Trial of Personalized Neoantigen Therapy plus Anti‐PD‐1 in Patients with Advanced Melanoma, Non‐Small Cell Lung Cancer, or Bladder Cancer
10.1016/j.cell.2020.08.053 · 2020 · External reference
PGV001, a Multi‐Peptide Personalized Neoantigen Vaccine Platform: Phase I Study in Patients with Solid and Hematologic Malignancies in the Adjuvant Setting
10.1158/2159-8290.cd-24-0934 · 2025 · External reference
Personalized Neoantigen Vaccine and Pembrolizumab in Advanced Hepatocellular Carcinoma: A Phase 1/2 Trial
10.1038/s41591-024-02894-y · 2024 · External reference
Challenges and Opportunities on Achieving an Adequate Delivery Efficiency and Immunogenicity with Peptide‐Based Anticancer Vaccines
10.1016/j.addr.2025.115675 · 2025 · External reference
Cell‐Penetrating Peptides Enhance Peptide Vaccine Accumulation and Persistence in Lymph Nodes to Drive Immunogenicity
10.1073/pnas.2204078119 · 2022 · External reference
In Vivo Characterization of the Physicochemical Properties of Polymer‐Linked TLR Agonists That Enhance Vaccine Immunogenicity
10.1038/nbt.3371 · 2015 · External reference
Peptide–TLR‐7/8a Conjugate Vaccines Chemically Programmed for Nanoparticle Self‐Assembly Enhance CD8 T‐Cell Immunity to Tumor Antigens
10.1038/s41587-019-0390-x · 2020 · External reference
Enhancement of Peptide Vaccine Immunogenicity by Increasing Lymphatic Drainage and Boosting Serum Stability
10.1158/2326-6066.cir-17-0607 · 2018 · External reference
10.3389/fimmu.2023.1125253
10.3389/fimmu.2023.1125253 · External reference
From Sewer to Saviour—Targeting the Lymphatic System to Promote Drug Exposure and Activity
10.1038/nrd4608 · 2015 · External reference
Enhancement of the Immunostimulatory Activity of a TLR7 Ligand by Conjugation to Polysaccharides
10.1021/acs.bioconjchem.5b00285 · 2015 · External reference
Lymph‐Node‐Targeted Cholesterolized TLR7 Agonist Liposomes Provoke a Safe and Durable Antitumor Response
10.1021/acs.nanolett.1c01968 · 2021 · External reference
10.1158/2326‐6066.cir‐13‐0223
10.1158/2326‐6066.cir‐13‐0223 · External reference
Pharmacokinetic Tuning of Protein‐Antigen Fusions Enhances the Immunogenicity of T‐Cell Vaccines
10.1038/s41551-020-0563-4 · 2020 · External reference
Optimized Lentiviral Backbone Induces Robust and Diverse T Cell Immunity against Neoantigens to Counteract Tumor Heterogeneity
10.1038/s41541-025-01199-6 · 2025 · External reference
Formation and Kinetics of MHC Class I‐Ovalbumin Peptide Complexes on Immature and Mature Murine Dendritic Cells
10.1046/j.1523-1747.2000.00084.x · 2000 · External reference
Self‐Assembly of Peptide Amphiphiles: From Molecules to Nanostructures to Biomaterials
10.1002/bip.21328 · 2010 · External reference
Proton‐Driven Transformable Nanovaccine for Cancer Immunotherapy
10.1038/s41565-020-00782-3 · 2020 · External reference
Hidden Hydrophobicity Impacts Polymer Immunogenicity
10.1039/d2sc07047b · 2023 · External reference
Next‐Generation Computational Tools for Interrogating Cancer Immunity
10.1038/s41576-019-0166-7 · 2019 · External reference
Poly(I:C) as Cancer Vaccine Adjuvant: Knocking on the Door of Medical Breakthroughs
10.1016/j.pharmthera.2014.09.010 · 2015 · External reference
A Systematic Review on Poly(I:C) and Poly‐ICLC in Glioblastoma: Adjuvants Coordinating the Unlocking of Immunotherapy
10.1186/s13046-021-02017-2 · 2021 · External reference
α‐PD‐1 Therapy Elevates Treg/Th Balance and Increases Tumor Cell pSmad3 That Are Both Targeted by α‐TGFβ Antibody to Promote Durable Rejection and Immunity in Squamous Cell Carcinomas
10.1186/s40425-018-0493-9 · 2019 · External reference
A Large Peptidome Dataset Improves HLA Class I Epitope Prediction across Most of the human Population
10.1038/s41587-019-0322-9 · 2020 · External reference
10.1038/s41586‐023‐06063‐y
10.1038/s41586‐023‐06063‐y · External reference
10.1038/nature23003
10.1038/nature23003 · External reference
10.1016/s0140‐6736(23)02268‐7
10.1016/s0140‐6736(23)02268‐7 · External reference
10.1101/142919
10.1101/142919 · External reference
10.1093/nar/gkaa379
10.1093/nar/gkaa379 · External reference
10.1093/bioinformatics/bty560
10.1093/bioinformatics/bty560 · External reference
Salmon Provides Fast and Bias‐Aware Quantification of Transcript Expression
10.1038/nmeth.4197 · 2017 · External reference
Moderated Estimation of Fold Change and Dispersion for RNA‐Seq Data with DESeq2
10.1186/s13059-014-0550-8 · 2014 · External reference
clusterProfiler 4.0: A Universal Enrichment Tool for Interpreting Omics Data
2021 · External reference
xCell: Digitally Portraying the Tissue Cellular Heterogeneity Landscape
10.1186/s13059-017-1349-1 · 2017 · External reference
